Key result
Insulin resistance is independently linked to higher left ventricular mass index in non-diabetic hemodialysis patients.
Why the study?
Insulin resistance is frequently recognized in patients with uremia and is thought to have a basic role in the pathogenesis of cardiovascular disease. This study evaluated the effect of insulin resistance on cardiovascular risk in non-diabetic patients receiving hemodialysis.
Cross-Sectional (n=186)
Answers are grounded in this paper and cite their sources.
IR may be associated with higher CV risk in non-diabetic HD patients; leaves open whether IR-targeted interventions improve outcomes.
BACKGROUND: Insulin resistance (IR) is frequently recognized in patients with uremia, and it is thought that IR has a basic role in the pathogenesis of cardiovascular disease. OBJECTIVE: To evaluate the effect of IR on cardiovascular risk in non-diabetic patients receiving hemodialysis (HD). METHODS: We performed a cross-sectional observational study that comprised 186 non-diabetic patients receiving HD (95 men; mean [SD] age, 46.4 [10.8] years; age range, 35-60 years) who had been receiving HD for 7.3 (3.5) years. Demographic variables and laboratory values were recorded. Insulin resistance was determined using the Homeostatic Model Assessment (HOMA), and the left ventricular mass index (LVMI) was calculated via echocardiography. RESULTS: According to HOMA-IR levels, patients were categorized as having IR (HOMA-IR score ≥2.5; n = 53) or not having IR (HOMA-IR score <2.5; n = 133). Insulin resistance was determined in 28.4% of study patients. Compared with the non-IR group, the IR group had been receiving HD longer; had greater body mass index; and had higher serum creatinine, uric acid, triglyceride, insulin, and C-reactive protein concentrations, leukocyte count, and LVMI (P < 0.05). Patients with increased LVMI had significantly higher body mass index, systolic blood pressure, serum cholesterol and C-reactive protein concentrations, and HOMA score. At multivariate analysis, systolic blood pressure (β = 0.22; P = 0.03) and HOMA score (β = 0.26; P = 0.01) affected LVMI. CONCLUSIONS: Insulin resistance and hypertension are independent risk factors for left ventricular hypertrophy in non-diabetic patients with uremia who are receiving HD. Further studies are needed to indicate the benefits of improving IR for cardiovascular mortality in this subgroup of patients with uremia.
No takes yet. Share an insight, caveat, or question.
Karakan et al. (2012) conducted a cross-sectional in Uremia in non-diabetic patients receiving hemodialysis (n=186). Insulin resistance (HOMA-IR ≥2.5) vs. No insulin resistance (HOMA-IR <2.5) was evaluated on Left ventricular mass index (LVMI) (β = 0.26, p=0.01). Insulin resistance (HOMA-IR score) was independently associated with increased left ventricular mass index in non-diabetic hemodialysis patients.
Synapse has enriched 10 related papers. Consider them for comparative context: